Skip to content
lifestyle.menstyle1.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
OKYO Pharma LTD
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
July 8, 2026
OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
July 7, 2026
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
May 23, 2026
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
April 29, 2026
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
April 7, 2026
OKYO Pharma Announces Chairman and Founder Acquires Shares
March 19, 2026
OKYO Pharma Announces Director Acquires Shares
March 19, 2026
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
March 19, 2026
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
March 18, 2026
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
February 23, 2026
←
Previous Page
1
2
3
Next Page
→